Bostankolu Değirmenci, B. Et Al. 2024. Clinical factors associated with autologous stem cell transplantation outcomes in multiple myeloma: upfront transplant with MEL200 remains the standard of care.. Annals of hematology , vol.103, no.1 , 269-283.

Bostankolu Değirmenci, B., Yegin, Z. A., Akdemir, Ü. Ö., Dede, A., Gündem, G. G., Özkurt, Z. N., ... Atay, L. Ö.(2024). Clinical factors associated with autologous stem cell transplantation outcomes in multiple myeloma: upfront transplant with MEL200 remains the standard of care.. Annals of hematology , vol.103, no.1, 269-283.

Bostankolu Değirmenci, Başak Et Al. "Clinical factors associated with autologous stem cell transplantation outcomes in multiple myeloma: upfront transplant with MEL200 remains the standard of care.," Annals of hematology , vol.103, no.1, 269-283, 2024

Bostankolu Değirmenci, Başak B. Et Al. "Clinical factors associated with autologous stem cell transplantation outcomes in multiple myeloma: upfront transplant with MEL200 remains the standard of care.." Annals of hematology , vol.103, no.1, pp.269-283, 2024

Bostankolu Değirmenci, B. Et Al. (2024) . "Clinical factors associated with autologous stem cell transplantation outcomes in multiple myeloma: upfront transplant with MEL200 remains the standard of care.." Annals of hematology , vol.103, no.1, pp.269-283.

@article{article, author={Başak Bostankolu Değirmenci Et Al. }, title={Clinical factors associated with autologous stem cell transplantation outcomes in multiple myeloma: upfront transplant with MEL200 remains the standard of care.}, journal={Annals of hematology}, year=2024, pages={269-283} }